Luke Bosso

• Served as Science Counsel to a major pharmaceutical company in federal multidistrict and state court litigation relating to allegations that a medicine caused various forms of cancer. Luke developed scientific defenses that led to exclusion of Plaintiffs’ experts in both federal and state litigation. He also developed key experts, deposed Plaintiffs’ experts, and coordinated scientific defenses during high-stake jury trials.
• Served as Science Counsel to a major company in federal multidistrict litigation relating to allegations that a medicine causes autism spectrum disorder and attention-deficient hyperactivity disorder. Luke serves as a core part of the joint defense group’s science team that strategically challenged Plaintiffs’ general causation theory leading to the exclusion of Plaintiffs’ experts and summary judgment for the entire litigation.
• Assisted pharmaceutical and medical device companies with responses to FDA, customers, and other third-party stakeholders regarding safety related inquiries, including pharmacovigilance signal detections and impurity investigations.
• Advised a cosmetic manufacturer on best practices for impurity investigations, testing strategies, and other legal considerations.

Luke Bosso focuses on toxic tort litigation from prelitigation risk assessments through jury trials. Leveraging his scientific background, Luke can independently analyze and synthesize complex scientific evidence that impacts his clients’ products. He routinely works with preeminent experts from the world’s leading scientific institutions to analyze issues surrounding exposure, risk, and medical causation. Luke has significant experience taking expert depositions and has successfully argued to exclude experts in high-stakes litigation, including large federal MDLs to state court proceedings in notoriously difficult jurisdictions. 

In addition to his litigation practice, Luke also advises companies about pre-litigation risk assessments for emerging safety-related inquiries. He helps companies respond to investigations and inquiries launched by regulatory bodies, customers, and other third-party stakeholders. He can also help in-house counsel implement best practices for investigating safety-related concerns and minimizing risk.

Prior to law school, Luke earned a Master of Science degree in Pharmacy, concentrating in Pharmaceutical Outcomes and Policy, which he leverages to distill complex technical issues for judges and juries. He also earned his law degree from Georgetown University Law Center. While attending law school, Luke served as the Georgetown Editor-in-Chief of the Food and Drug Law Journal. He also practiced as a student attorney at Georgetown’s medical-legal partnership clinic and taught Street Law in D.C. Public Schools.